Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia

Y Zhang, XB Zhu, J Gan, L Song, C Qi, N Wu… - Journal of Affective …, 2024 - Elsevier
Abstract Objective Impulse control behaviors (ICBs) and apathy are believed to represent
opposite motivational expressions of the same behavioral spectrum involving hypo-and …

Advantages and Disadvantages of Current Therapeutics and Phytochemicals for Age-Related Brain Disorders

ABA Bari, M Krishnan, S Babu - … Effects of Phytochemicals in Brain Ageing, 2024 - Springer
Age-related brain disorders are a group of conditions characterised by the progressive loss
of structure and function of neurons in the brain. These disorders primarily affect older …

Molecular Docking of Zingerone and Gamma-Mangostin to Inhibit MAO-B and Catechol-O-Methyltransferase (COMT) in the Treatment of Parkinson's Disease

AA Saraiva, JPO da Silva, JVM Sousa… - Research, Society and …, 2022 - rsdjournal.org
Currently, there is no drug that has proven neuroprotective properties in Parkinson's
disease. The best-known drug is levodopa, which acts as inhibitors of the MAO-B and COMT …

Caracterización de pacientes con enfermedad de Parkinson del Hospital Provincial Clínico Quirúrgico “Saturnino Lora Torres”.

NS Tamayo, LMR Aguirre, JB Ortega, MV Hernández… - SPIMED, 2023 - revspimed.sld.cu
Introducción: Durante la última década ha ocurrido un incremento en la incidencia y
prevalencia de la enfermedad de Parkinson y, por ende, de la mortalidad a causa de esta …

[PDF][PDF] Исследование роли бета-синуклеинa в регуляции дофаминовой трансмиссии синаптическими везикулами

ВЛ Бухман - ibmc.msk.ru
HVA–3-метокси-4-гидроксифенилуксусная (гомованилиновая) кислота; IPTG–изопропил
бета-D-тиогалактопиранозида; L-DOPA–L-3, 4-дигидроксифенилаланин; LC-MS …

[引用][C] NGHIÊN CỨU XẠ HÌNH LÀM TRỐNG DẠ DÀY TRONG CHẨN ĐOÁN LIỆT DẠ DÀY Ở BỆNH NHÂN BỆNH PARKINSON

TT HÙNG